National Institute for Health Research (NIHR) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Social prescribing could empower patients to address non-medical problems in their lives, NIHR
NIHR Evidence. Many GP practices are exploring social prescribing, which is a way of linking patients to sources of support in the local community. Social prescribing addresses non-medical needs such as loneliness and financial difficulties. The NHS employs link workers to connect patients with local support networks. During the COVID-19 crisis, link workers may have an even greater role to play in supporting vulnerable patients who are isolated at home. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 29, 2020 Category: Consumer Health News Source Type: news

NIHR Alert: Largest ever trial into a rare cancer of the urinary system shows clear benefits of chemotherapy after surgery, NIHR Evidence
The largest trial ever conducted into the disease found that giving chemotherapy halves the risk of the cancer coming back after surgery. The results provide clear evidence for this approach to become the new standard of care for patients whose disease has not spread to other parts of the body. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 27, 2020 Category: Consumer Health News Source Type: news

£ 7 million government investment in Patient Recruitment Centres for commercial clinical research
(National Institute for Health Research) The new research centres will increase capacity within the NHS to deliver vital research for patients, while decreasing the time it takes to set-up late-phase commercial trials within the NHS -- improving the UK's competitiveness in the global market and providing opportunities for patients to benefit from early access to innovation. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 22, 2020 Category: Infectious Diseases Source Type: news

Cochrane identifies its priority areas for future COVID-19 work and lists other critical questions for the research community
Cochrane today announces itsCOVID-19 priority areas of work over the next six months to help meet the healthcare evidence needs of policymakers, guideline developers and clinicians; and makes available a list of additional priority questions to help guide the work of other research organizations.Since 18 March, Cochrane has been gathering some of the most important questions related to the COVID-19 pandemic from health researchers, clinicians, policymakers, patients and carers, as well as important external stakeholders including theWorld Health Organization (WHO), the UK National Institute for Health Research (NIHR) an...
Source: Cochrane News and Events - May 21, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Cognitive behavioural therapy reduces the impact of dissociative seizures
(NIHR Maudsley Biomedical Research Centre) Scientists have found that adding cognitive behavioral therapy (CBT) to standardized medical care gives patients with dissociative seizures longer periods of seizure freedom, less bothersome seizures and a greater quality of life, in a study published in Lancet Psychiatry today and by the Cognitive behavioral therapy for adults with dissociative seizures (CODES) study group funded by National Institute for Health Research (NIHR). (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 20, 2020 Category: International Medicine & Public Health Source Type: news

Could a drug combination prevent people with the eye disease uveitis lose their sight?
Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £ 2.5 million by the National Institute for Health Research (NIHR). The study will be co-ordinated by the University's Bristol Trials Centre (CTEU). (Source: University of Bristol news)
Source: University of Bristol news - May 12, 2020 Category: Universities & Medical Training Tags: Grants and Awards, Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences; Press Release Source Type: news

Could a drug combination prevent people with the eye disease uveitis lose their sight?
(University of Bristol) Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £ 2.5 million by the National Institute for Health Research (NIHR). The study will be co-ordinated by the University's Bristol Trials Centre (CTEU). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2020 Category: International Medicine & Public Health Source Type: news

New call for research on the risk factors, transmission and prevalence of coronavirus
A new call for research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2, has been launch by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). (Source: Medical Research Council General News)
Source: Medical Research Council General News - May 7, 2020 Category: Research Source Type: news

Bristol researchers contribute to COVID-19 rapid evidence reviews
Researchers from across the University of Bristol are contributing to COVID-19 rapid evidence reviews, co-ordinated by the National Institute for Health Research Applied Research Collaboration West (NIHR ARC West). (Source: University of Bristol news)
Source: University of Bristol news - May 4, 2020 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

COVID-19 vaccine begins human trial stage
Researchers at the University of Oxford have begun testing a COVID-19 vaccine in human volunteers this week. The phase I trial was funded by UKRI and NIHR as part of the rapid research response. (Source: Medical Research Council General News)
Source: Medical Research Council General News - April 24, 2020 Category: Research Source Type: news

NIHR and UKRI launch call for research on COVID-19 and ethnicity
The NIHR and UKRI are jointly calling for research proposals to investigate emerging evidence of an association between ethnicity and COVID-19 incidence and adverse health outcomes. (Source: Medical Research Council General News)
Source: Medical Research Council General News - April 23, 2020 Category: Research Source Type: news

Calculating early warning scores before they reach hospital can help the sickest patients
Recording National Early Warning Scores (NEWS) when a patient is urgently referred to hospital can improve the process of care for the sickest patients and reduce the time taken to get to hospital, according to a National Institute for Health Research (NIHR) funded study at the University of Bristol published in the British Journal of General Practice (BJGP) today [7 April]. National Early Warning Scores help clinicians recognise when patients are at risk of deterioration, for example as a result of infection such as sepsis. (Source: University of Bristol news)
Source: University of Bristol news - April 7, 2020 Category: Universities & Medical Training Tags: Health, International; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Researchers appeal to public for help to assess mental health impact of the COVID-19
(NIHR Maudsley Biomedical Research Centre) Scientists are appealing to the public for help to assess the mental health impact of the COVID-19 pandemic, with the aim to inform and improve future policies concerning pandemics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 7, 2020 Category: International Medicine & Public Health Source Type: news

Help prioritize topics for Cochrane COVID-19 Rapid Reviews
Help prioritize topics for Cochrane Rapid Reviews on the current COVID-19 pandemic. Although we welcome all responses, at this stage Cochrane will be prioritizing review titles which are the most important to healthcare workers, particularly those working in low- and middle-income countries.Cochrane is engaging with a range of stakeholders inside and outside of Cochrane to build a bank of important questions emerging from the COVID-19 pandemic. Questions have been submitted by Cochrane Groups and users as well as external stakeholders including theWorld Health Organization (WHO), theUK National Institute for Health Rese...
Source: Cochrane News and Events - April 1, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

NIHR Signal: Melatonin shows potential for reducing delirium among older people after surgery
Expert commentary is provided of a systematic review and meta-analysis (6 studies; n=1155) which reported that taking melatonin around time of surgery is linked with lower odds of delirium onset in older people vs placebo or no treatment (~15% vs. ~20%). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 2, 2020 Category: Consumer Health News Source Type: news